Market Place
Sourcing Support
All News #Library
Sciences
JAAD Study Validates AdvanceAD-Tx in AD
19 Feb 2026 //
GLOBENEWSWIRE
New Data Confirms Performance of DecisionDx-Melanoma
14 Nov 2025 //
GLOBENEWSWIRE
New Evidence Supports DecisionDx-SCC In NCCN High-Risk Carcinoma
25 Aug 2025 //
GLOBENEWSWIRE
FDA Grants Breakthrough to Castle’s DecisionDx-Melanoma Test
23 Jul 2025 //
GLOBENEWSWIRE
Castle Biosciences earns Top Workplaces Awards for Strong Culture
17 Jul 2025 //
GLOBENEWSWIRE
Castle Biosciences to Present at 2025 Jefferies Global Conference
21 May 2025 //
GLOBENEWSWIRE
DecisionDx-Melanoma Test Tops 200K Orders for Patients
28 Apr 2025 //
GLOBENEWSWIRE
Castle Bio`s DecisionDx-Melanoma Test Supports Risk-Based Care
01 Apr 2025 //
GLOBENEWSWIRE
Castle`s DecisionDx®-Melanoma Aids Melanoma Management
12 Dec 2024 //
BUSINESSWIRE
Castle Bio Presents Melanoma Data at Dermatopathology 66th Meeting
08 Nov 2024 //
BUSINESSWIRE
Castle Biosciences’ Test Reduces Unnecessary SLNB Procedures
06 Nov 2024 //
BUSINESSWIRE
DecisionDx-SCC Identifies High-Risk SCC Patients For Adjuvant Radiation
29 May 2024 //
BUSINESSWIRE
Castle Biosciences Announces Publication of Peer-Reviewed
04 Dec 2020 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.